So-called “delinking” policies continue to be discussed in Congress. Among several glaring problems — including a rejection of free market performance-based incentives that lower drug costs for consumers — if enacted, “delinking” would hand a financial windfall totaling up to
As Congress considers anti-PBM legislation in the new year, it is important lawmakers are aware that allowing the government to dictate the winners and losers in the health care system, according to policymakers and experts, will do nothing to actually
Given this growing challenge, pharmacy benefit managers (PBMs) have never been more essential. For both public programs and private insurance, PBMs are actively engaged in keeping prescription drug costs down and making medications more affordable for individual patients.
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association, discusses how recent proposals being considered by Congress targeting pharmacy benefits would increase health care costs at a time when premiums continue to rise
The need for reliable mail-service pharmacies has been widely cited in the recent firestorm over potential modifications to operations at the United States Postal Service, raising concerns that people are not getting their medications delivered on time. While election-year political
Our collective will and intellects are being called upon to manage COVID-19, save lives, and restore our economy. During this public health emergency, it is crucial that every sector of our health care system step up to the challenge. And
Simply put, the core mission for PBMs is to be the primary advocate for consumers and health plans in the fight to keep prescription drugs accessible and affordable.
PBMs leverage competition between drugs to create savings for patients.
©2024 PCMA. All Rights Reserved.
